BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Life Recovery Systems Receives FDA Clearance For Its ThermoSuit(R) System


9/28/2006 9:46:36 AM

ALEXANDRIA, La., Sept. 27 /PRNewswire/ -- Life Recovery Systems, HD, LLC of Alexandria, LA and Kinnelon, NJ, an emerging provider of groundbreaking medical devices for the emergency medical care market, announced today that its ThermoSuit(R) System has been granted clearance to market by the FDA for in-hospital hypothermia therapy.

The ThermoSuit System uses innovative technology to rapidly cool a patient's core temperature. It consists of a disposable body suit and a means to pump coolant within the suit over the skin of the patient. It is the first device for patient temperature management that conveniently provides a thin layer of rapidly flowing liquid coolant in direct contact with the skin. This approach gives the ThermoSuit System outstanding capabilities to rapidly and non-invasively change patient temperature. It has been designed for ease of use for clinicians who treat patients indicated for cooling therapy, and has the potential to quickly cool these patients conveniently and rapidly.

The system will be on display and operational at Booth 2676 at the Annual Conference of the American Heart Association in Chicago in November 2006.

"The FDA marketing clearance of the ThermoSuit System is an important first step in achieving our company's mission," said John DiLiddo, Life Recovery Systems' vice president of marketing and sales. "With the introduction of the ThermoSuit System for use in the hospital, physicians and nurses will now have a convenient, easy-to-use tool in the delivery of emergency hypothermia therapy."

Evolving AHA Standards of Care as of November 2005 recommend that "unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest should be cooled to 32 degrees C to 34 degrees C for 12-24 hours when the initial rhythm was ventricular fibrillation. Such cooling may also be beneficial for other rhythms or in-hospital cardiac arrest."

Life Recovery Systems, HD, LLC is focused on developing and providing groundbreaking, innovative medical devices for the emergency medical care market. To learn more, visit http://www.life-recovery.com.

Life Recovery Systems, HD, LLC

CONTACT: Luisa Cahill for Life Recovery Systems, +1-617-921-8087,lc@seidlerbernstein.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES